Clinical Trial Update: Quetiapine XR for Cognitive and Functional Disability in Clinically Stable Patients With Bipolar Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating quetiapine XR for cognitive and functional impairment in clinically stable bipolar disorder patients was terminated; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Cognitive Impairment

Drugs mentioned

• SEROQUEL XR (Quetiapine)

Snippet

Sponsor: Emory University | Conditions: Bipolar Disorder, Cognitive Impairment | Phase 4 | Status: TERMINATED | Results posted: 2014-03-28